Albemarle

Albemarle Reaches New Multi-Year High Following Sixth Analyst Upgrade This Month

美国雅保

Citigroup

Citigroup Raises Albemarle PT to $180 from $150 with Neutral Rating

Albemarle's 15-Minute Chart Indicates RSI Overbought and KDJ Death Cross

Albemarle: Oppenheimer maintains Outperform, raises PT to $207 from $109.

Albemarle: Truist Securities upgrades to Buy, raises PT to $205 from $125.

Catalyst<ul> <li>Most analysts rate ALB Buy or Strong Buy showing broad institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a weak state and we need to pay attention to the risk of decline.</li> <li>Fund flow analysis indicates negative trends across all order size buckets suggesting investor withdrawal.</li> <li>Bearish signals are obviously dominant (3 bearish vs 0 bullish) according to technical analysis.</li></ul>

Key Factors

Albemarle (ALB) surged 5.83% on January 20, 2026, with $770 million in trading volume as lithium market recovery and analyst upgrades boosted investor confidence.HSBC upgraded Albemarle to Buy with a $200 price target, citing rising lithium prices, contract renegotiations, and strong balance sheet position.Albemarle shares rose 5.21% after-hours following HSBC's Buy upgrade and a $200 price target, reflecting optimism about lithium demand and company positioning.

Recent Updates

ALB News